65,437 trials
Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC) · Nonsmall Cell Lung Cancer, Stage IIIB · Nonsmall Cell Lung Cancer, Stage IV
Primary: Progression-free Survival (PFS) — 8.2; 8.1 Months — p=0.4698
Head and Neck Cancer
Primary: Change in Immune-based Biomarker Expression at Baseline and 2 Months — 0; 1; 2 Participants — p=<0.036
Chronic Cough · Eosinophilic Bronchitis · Asthma
Primary: Change From Baseline in 24-hour Cough Frequency at 14 Weeks — 17.0; 17.0; 12.6; 10.6 Coughs/hour — p=0.99
Tetanus
Primary: Proportion of Volunteers With an Increase of Anti-tetanus Neutralizing Antibody Titers Over Protective Level — 56; 61; 29; 48 Participants
Advanced Solid Tumor
Primary: Dose-normalized Maximum Observed Plasma Concentration (Cmax) of Total Lurbinectedin: Alone and in Combination With Bosentan. — 20.71; 21.39 μg/L/mg
Attention Deficit Disorder With Hyperactivity · Conduct Disorder
Primary: The Nisonger Child Behavior Rating Form- Typical Intelligence Quotient (NCBRF-TIQ) Conduct Problem Subscale Score — 20.4; 25.7; 26.0; 26.0 score on a scale
Treatment of Patients Suffering From Overactive Bladder (OAB)
Primary: ≥50% Decrease in Mean Urinary Urgency Incontinence (UUI) Episodes — 76.4 Percentage of Responders
Healthy
Primary: Pharmacokinetics (PK): Maximum Concentration (Cmax) of Rosuvastatin — 8.92; 15.2 nanogram per millilitre (ng/mL)
Stevens-Johnson Syndrome · Toxic Epidermal Necrolysis
Primary: Complete Skin Healing Time, Day, Medium [Full Range] — 10.0 days
Medication Abuse
Primary: Percentage of PDMP Checks Conducted During High-risk Prescriptions — 8187; 6322; 13360; 23328 health care encounters
Osteoarthritis, Knee
Primary: Change in Numerical Rate Score (NRS) for Pain — 0.67; -0.73; -1.25; -1.21 units on a scale
Harassment, Non-Sexual · Harassment, Sexual · Bullying, Workplace
Primary: Stress — 17.6; 13.1 score on a scale
Iron-deficiency
Primary: Hb (g/dl) at E2 — 13.07 g/dl — p=0.031
Transgender · Depression · Anxiety
Primary: Depression: Score on the Overall Depression Severity & Impairment Scale (ODSIS) — 9.68; 4.82 score on a scale
Perimenopause-Related Depression
Primary: Center for Epidemiologic Studies-Depression (CES-D) Scale Mean Total Score — 12.96; 18.02; 11.53; 9.43 Units on a scale